Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Phase II Comparative Study to Compare Efficacy & Safety of Taxotere®/Carboplatin Combination Therapy vs Sequential Therapy w/ Taxotere® Then Carboplatin as Second-line Treatment of Patients w/ Relapsed, Platinum-sensitive Ovarian Cancer

NCT00090610 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00090610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00090610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Phase II Comparative Study to Compare Efficacy & Safety of Taxotere®/Carboplatin Combination Therapy vs Sequential Therapy w/ Taxotere® Then Carboplatin as Second-line Treatment of Patients w/ Relapsed, Platinum-sensitive Ovarian Cancer
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
October 31, 2009
Enrollment
150 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer